Clinical Trial

Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy

Study acronym: CARDIAC-OAT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 5, 2025 (before its estimated January 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.
Trial Details
NCT Number NCT06858345
Lead Sponsor Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Conditions Preeclampsia
Enrollment 50 participants
Start Date 2025-01-01
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-01-15 (estimated)
Updated on ClinicalTrials.gov 2025-03-05